Emmons GT - Search Results

1

Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

Diéras V, Bonnefoi H, Alba E, Awada A, Coudert B, Pivot X, Gligorov J, Jager A, Zambelli S, Lindeman GJ, Charpentier E, Emmons GT, Garcia-Ribas I, Paridaens R, Verweij J. Diéras V, et al. Among authors: emmons gt. Breast Cancer Res Treat. 2019 Sep;177(2):383-393. doi: 10.1007/s10549-019-05305-w. Epub 2019 Jun 6. Breast Cancer Res Treat. 2019. PMID: 31172407 Clinical Trial.

2

Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.

Blakeley JO, Grossman SA, Mikkelsen T, Rosenfeld MR, Peereboom D, Nabors LB, Chi AS, Emmons G, Garcia Ribas I, Supko JG, Desideri S, Ye X. Blakeley JO, et al. J Neurooncol. 2015 Oct;125(1):123-31. doi: 10.1007/s11060-015-1876-0. Epub 2015 Aug 19. J Neurooncol. 2015. PMID: 26285766 Free PMC article. Clinical Trial.

3

Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.

Emmons GT, Argenti R, Martin LL, Martin NE, Jensen BK. Emmons GT, et al. J Clin Pharmacol. 2004 Aug;44(8):901-5. doi: 10.1177/0091270004267588. J Clin Pharmacol. 2004. PMID: 15286094 Clinical Trial.

4

Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects.

Shah B, Emmons G, Rohatagi S, Martin NE, Jensen BK. Shah B, et al. Am J Ther. 2003 Sep-Oct;10(5):356-62. doi: 10.1097/00045391-200309000-00008. Am J Ther. 2003. PMID: 12975720 Clinical Trial.

5

Exploring the feasibility of using the DBS technique for metabolite radioprofiling.

Wang L, Zeng Z, Emmons G. Wang L, et al. Bioanalysis. 2010 Aug;2(8):1365-71. doi: 10.4155/bio.10.100. Bioanalysis. 2010. PMID: 21083337

6

Pharmacokinetic considerations as to when to use dried blood spot sampling.

Emmons G, Rowland M. Emmons G, et al. Bioanalysis. 2010 Nov;2(11):1791-6. doi: 10.4155/bio.10.159. Bioanalysis. 2010. PMID: 21083484

7

Impact of various factors on radioactivity distribution in different DBS papers.

Ren X, Paehler T, Zimmer M, Guo Z, Zane P, Emmons GT. Ren X, et al. Among authors: emmons gt. Bioanalysis. 2010 Aug;2(8):1469-75. doi: 10.4155/bio.10.96. Bioanalysis. 2010. PMID: 21083347

8

Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practices.

Evans CA, Bruce C, Emmons GT, Gallenberg L, Ji QC, Kinter LB, Musvasva E, Wickremsinhe E. Evans CA, et al. Among authors: emmons gt. Bioanalysis. 2010 Aug;2(8):1355-9. doi: 10.4155/bio.10.101. Bioanalysis. 2010. PMID: 21083334 No abstract available.

9

Use of dried blood spots in drug development: pharmacokinetic considerations.

Rowland M, Emmons GT. Rowland M, et al. Among authors: emmons gt. AAPS J. 2010 Sep;12(3):290-3. doi: 10.1208/s12248-010-9188-y. Epub 2010 Apr 10. AAPS J. 2010. PMID: 20383669 Free PMC article.

10

Determination of a specific 5-HT2a antagonist (M100907) in rat and dog plasma at the femtomole/milliliter level by gas chromatography-mass spectrometry.

Emmons GT, Danison TH, Steele D, Sproles GD. Emmons GT, et al. J Chromatogr B Biomed Sci Appl. 1998 Sep 25;716(1-2):161-9. doi: 10.1016/s0378-4347(98)00315-6. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9824229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters